
AI designs peptides for ‘undruggable’ diseases
A new AI-powered approach is tackling the challenge of 'undruggable' diseases by designing peptides ...
A new AI-powered approach is tackling the challenge of 'undruggable' diseases by designing peptides ...
Rigel Pharmaceuticals has announced the enrolment of the first patient in a Phase I trial evaluating...
A new study suggests that targeting serotonin in the gut, rather than the brain, could lead to antid...
A new AI-powered approach is tackling the challenge of 'undruggable' diseases by designing peptides that can bind to and destroy previously untreatable proteins....
Rigel Pharmaceuticals has announced the enrolment of the first patient in a Phase I trial evaluating fostamatinib for sickle cell disease....
New study reveals that TLE6 protein deficiency causes male infertility in mice. These findings suggest potential genetic causes and future treatment avenues for male infertility....
Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying early biomarkers for Parkinson's disease (PD)....
Unlock Exclusive Industry Insights